| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8519529 | Future Journal of Pharmaceutical Sciences | 2016 | 16 Pages |
Abstract
From all the evaluation studies, the release of SVD from its dosage from (F9) was sustained and thereby expected to provide patient compliance with reduced frequency of administration and side effects by avoiding the sudden burst release.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
Venkateswarlu Kambham, Chandrasekhar Kothapalli Bonnoth,